Product synthetic-chemistry-Custom-synthetics

Home > products > synthetic-chemistry> Custom-synthetics

Catalog	name	Description	price
R-R-0246	alpha-Maltose CAS: 4482-75-1	Alpha-maltose is a maltose that has alpha-configuration at the reducing end anomeric centre.α-maltose is a natural product found in Cyperus esculentus, Phytelephas aequatorialis, and other organisms with data available.Maltose is a metabolite found in the aging mouse brain.	price>
R-R-0248	Ndb-fructan	Ndb Fructan contains specific information about fructans that have been characterized and included in the database. This information may include detailed information on the molecular structure, chain length, branching mode, and functional characteristics of fructans. Researchers can use this information to study the specific properties and functions of fructans in various applications such as food science, agriculture, or medicine.	price>
R-R-0255	1-O-Alpha-D-glucopyranosyl-D-fructose	1-O-Alpha-D-glucopyranosyl-D-fructose/Trehalulose/CAS 51411-23-5 is a sugar that is found in plants, animals, and fungi. It is a reaction product of glucose with the enzyme trehalase, which cleaves off two molecules of water to form one molecule of glucose and one molecule of trehalulose. Trehalulose has been shown to be an inhibitor of phosphofructokinase, an enzyme involved in glycolysis. This inhibition can be reversed by the addition of ATP or pyruvate kinase. Trehalulose also has been shown to inhibit the growth of cells by interfering with protein synthesis. Trehalulose may have biological functions including dietary uses as a replacement for sucrose or lactose due to its low calorie content and high level of sweetness.	price>
R-R-0259	Methyl 6-amino-deoxy-galactoyranoside CAS 5155-47-5	Methyl 6-Amino-6-deoxy-α-D-glucopyranoside is an intermediate in synthesizing Ranimustine (R120030), a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It can be used in biological study of synthesis of anti-EGFR antibody-drug conjugates. It can also be used in therapeutic use and biological study of BCMA (B-Cell Maturation Antigen) antigen binding proteins.	price>
R-R-0286	PSMA-1007	PSMA-1007 is a novel Glu-Ureido-type prostate-specific membrane antigen (PSMA) inhibitor. [18F]PSMA-1007 is a prostate specific membrane antigen (PSMA) ligand for positron emission tomography (PET) imaging of prostate cancer.	price>
R-R-0287	PSMA11	PSMA-11/HBED-CC-PSMA/CAS .1366302-52-4 is a positron emission tomography (PET) tracer. PSMA-11 detects prostate cancer relapses and metastases by binding to the extracellular domain of prostate-specific membrane antigen (PSMA).	price>
R-R-0288	FAP inhibitors	FAP inhibitors, also known as fibroblast activation protein inhibitors, are a type of medication that block the activity of the FAP enzyme.By inhibiting FAP activity, these inhibitors can potentially slow down tumor growth and metastasis, as well as enhance the response to chemotherapy and immunotherapy. They may also have anti-inflammatory effects and modulate the tumor microenvironment.	price>
R-R-0308	Pentixafor CAS: 1341207-62-2	Pentixafor is a medicinal compound that has been developed as an anticancer agent. This compound is an analog of the CXCR4 receptor inhibitor, which is found in human urine and Chinese medicinal herbs. Pentixafor works by inhibiting kinases that are involved in cancer cell growth and survival, leading to apoptosis or programmed cell death. It specifically targets tumor cells and prevents them from spreading to other parts of the body. Pentixafor has shown promising results in preclinical studies for the treatment of various types of cancer, including breast, prostate, and lung cancer. Its ability to selectively target cancer cells makes it a potential breakthrough in cancer treatment research.	price>
R-R-0330	DCL (PSMA inhibitor) (ACUPA)	DCL (PSMA inhibitor) (ACUPA) is an amino-modified amino acid and a new type of inhibitor that has a highly inhibitory effect on prostate-specific membrane antigen (PSMA). It is introduced into polypeptides through chemical synthesis, thereby changing the properties and activity of the polypeptide. ACUPA-modified amino groups have stability and water solubility, which can enhance the affinity and selectivity of peptides, thereby improving the efficacy and biological activity of peptides. It can also alter the metabolism and distribution of peptides.	price>
R-R-0336	PSMA I&F	PSMA I&F is crucial for the management of prostate cancer patients as it facilitates early detection of recurrent or metastatic diseases and allows for tailored treatment methods based on individual reactions over time.	price>

...